A deficiency of prostacyclin (PGI2) production by the vascular endothelium might underline the severe vasoconstriction and intravascular thrombosis that characterise meningococcal shock. The effect on PGI2 synthesis by human umbilical vein endothelial cells (HUVEC) in culture was examined in sera from children with meningococcal shock, healthy adults, and children with other febrile illnesses. In comparision with adult controls, PGI2 synthesis was reduced when HUVEC were incubated with the sera from 10 of 13 patients with meningococcal shock. A similar defect was observed with only four of 20 sera from children with other febrile illnesses. The effect of sera from patients with meningococcal shock on HUVEC was reversible with normal serum, and seems to be due to the absence of a factor necessary for PGI2 production rather than an inhibitor.
Despite early diagnosis and appropriate treatment the mortality from meningococcal infection has not decreased over the last 30 years. The case mortality overall is 10% and rises to an unacceptable 40% for those with septicaemia and shock.' Attempts to improve the prognosis have so far been hampered by a lack of understanding of the pathophysiology of the disorder.
Clinical observation suggests that there are three major processes involved in the pathogenesis of meningococcal shock. Firstly, an increase in vascular permeability allows albumin to leak from the circulation, resulting in profound hypovolaemia and oedema.2 Secondly, intense vasoconstriction of some vascular beds and dilatation of others leads to impaired organ perfusion.3 Thirdly, intravascular thrombosis of both large and small vessels associated with platelet and clotting factor consumption intensifies tissue ischaemia. 4 These three features suggest that in meningococcal sepsis there is disruption of the homoeostatic function of the endothelium that normally maintains vascular permeability and thromboresistance.
Disseminated intravascular coagulation, with activation of clotting factors and deposition of fibrin within the microvasculature, has been considered to be an essential component of meningococcal disease. Several studies have documented both thrombocytopenia and derangement of coagulation.4 5 However, the mechanism responsible for the thrombocytopenia and the role of the disordered endothelialplatelet interactions in the pathophysiology of meningococcal infection have not been well studied.
Prostacyclin (PGI2) is a potent inhibitor of platelet aggregation and a powerful vasodilator.6 It is released from membrane bound arachidonic acid and is actively produced by the vascular endothelium. Together with other important endothelium derived platelet inhibitory factors, such as nitric oxide,7 PGI2 has an important role in thromboresistance. PGI2 production increases appreciably in response to hypoxia and stress,8 suggesting that under these circumstances it may be particularly important in preventing intravascular platelet activation and tissue ischaemia.
We postulated that a deficiency of PGI2 synthesis by the endothelium might be involved in the intravascular thrombosis and vasoconstriction seen in meningococcal disease. We suggest that this defect may be due to the absence of a factor necessary for PGI2 production or the presence of an inhibitor in the serum of patients with the disorder. We therefore investigated the effect of sera from patients with meningococcal shock on endothelial PGI2 production, and have compared this with that seen from sera from children with other febrile illnesses.
Patients and methods

PATIENTS WITH MENINGOCOCCAL DISEASE
Twenty three children (mean age 4-6 years; range 0-3 to 12-7 years) with severe meningococcal disease, referred to the Hospital for Sick Children, Great Ormond Street over the last six years, were studied. The diagnosis was made clinically on the basis of a characteristic purpuric rash in all cases and was confirmed by culture and/or serum antigen test in 18 patients. The haemophilus rapid antigen test was negative in the remaining patients. Shock was detected in 18 patients, this was defined by at least two of the following: impaired peripheral perfusion, as signified by poor capillary return, oliguria (less than 1 ml/kg/hour) or hypotension (at least 2 SD below the mean for age). Serum was available, in the acute phase, from only 13 of the patients with meningococcal shock.
CONTROLS (a) Healthy adults
Serum was collected from 12 hospital workers who did not have a history of significant disease. This department has previously compared normal childhood and adult sera in the bioassay employed in this study and has not found any difference between the groups. Adult sera were therefore used to standardise the assay because of the ethical and logistic difficulties involved in obtaining samples from normal children.
(b) Children with other febrile illnesses Serum was obtained from 20 children admitted to this hospital. Seven had non-meningococcal meningitis or encephalitis, one septicaemia, two Kawasaki disease, four toxic shock syndrome, two polyarteritis, and four had mild febrile illnesses. Shock, as defined by the criteria above, was diagnosed in six of these patients: four with toxic shock syndrome, one with haemophilus meningitis, and one with bacteroides septicaemia.
platelet aggregation, crossover experiments were performed. The culture supernatants used for the initial assay were removed and the cells were reincubated with fresh medium containing 20% control serum for 10 minutes. The culture supernatants were then assayed for recovery of PGI2 activity.
MEASUREMENT OF 6-KETo PGFIa
In order to confirm the results of the bioassay, the stable metabolite 6-keto PGFIa was measured using a radioimmunoassay kit (Amersham). 6-Keto PGF,l was measured in culture supernatants after incubation of HUVEC with the sera from seven children with meningococcal shock, which had been found not to induce PGI2 production employing the bioassay method and eight normal adult controls. COLLECTION The difference between the sera from the patients with meningococcal shock and the adult controls demonstrated by bioassay was confirmed using the 6-keto PGFia radioimmunoassay. On incubation of HUVEC with sera from meningococcal shock patients, the median 6-keto PGF10 detected was 4-2 ng/ml (range 2-7-6-6) in comparison to 11-3 ng/ml (range 2-2-31) with HUVEC incubated with control sera (rank sum test, p<0 03).
CROSSOVER EXPERIMENTS
When HUVEC previously cultured with sera from patients with meningococcal shock were reincubated with normal serum there was a significant increase in PGI2 production (rank sum test, p<003) (fig 2) .
CHARACTERISATION OF THE DEFECT
Heating sera from patients with meningococcal shock to 56°C for either 10 or 30 minutes did not affect its activity. Storage of these sera for more than two weeks at 4°C did not change their effect on PGI2 synthesis. Mixing experiments, employing the bioassay, have shown that addition of as little as one part n three parts serum from patients coccal shock, restores the ab endothelial PGI2 production shown), suggesting that nor augmenting the meningococcal than reversing an inhibitor. the records of 19 of the 23 children with severe meningococcal disease. In the first 24 hours after admission, 79% of these patients were thrombocytopenic but only 21% had low fibrinogen concentrations (fig 3) . Platelet aggregation studies were performed on two patients with meningococcal shock. A poor response to ADP and adrenalin was observed, implying that in vivo platelet activation had occurred.
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